(0) items in cart / view cart / checkout  
 
  Chemicals
  Company Profiles
  Country Analyses
  Energy and Utilities
  Food & Beverage
  In Vitro Diagnostics
  Medical Devices
  Pharmaceuticals & Biotechnology
 
 
  Advertising
Aerospace, Defense
Automotive
Banking
Biotechnology
Business Services
Chemicals
Company Reports
Construction
Consumer Goods
Countries
Diagnostics
Energy, Environment
Food & Beverages
Government
Healthcare
IT
Manufacturing
Media
Medical Devices
Pharmaceuticals
Retailing
Sales & Marketing
Sourcing
Telecommunications
Transportation
Travel, Entertainment
 
Home > Pharmaceuticals & Biotechnology Animal Health >  Animal Health Market Consolidation: Who will not survive?

Animal Health Market Consolidation: Who will not survive?




- Will the industry consolidate, decentralize, or undergo a bimodal transformation?

- How will the current trends affect the major market segments? 

- Which companies will enter the market and which will not survive? 

This new 83-page report from VPGMarketResearch analyzes strategies, marketing tactics and technological know-how of the world's leading animal health companies, including:

Five-year forecasts for:

- Major market segments

- Key geographic regions 

 Company Profiles
 
Bayer Animal Health
 
 - Considering selling animal health division
 - Plans to invest in Kiel
 - Rising demand for collars
 - Focusing on parasiticides and anti-infectives
 - Strong position in parasiticides
 - Animal health R&D
 - Worldwide marketing network
 - Emerging markets
 - Re-registering existing products
 - Present structure
 - Diverse businesses
 - Challenged by animal disease outbreaks
 - Europe's premier research organization
 - Animal health R&D
 - Crop science segment
 - Monsanto acquisition
 - Chairman Werner Baumann
 - Supervisory board
 
Boehringer Ingelheim
 
 - Sales and growth
 - Animal health is one of the major pillars
 - Swine vaccine Ingelvac circoflex
 - Merial animal health
 - U.S. animal health market position
 - Promoting Eqvalan line
 - Seeking to reinforce position in livestock market
 - Strategies supported by collaborations
 - Merial R&D programs
 - Collaborative efforts
 - Porcine Reproductive and Respiratory Syndrome (PRRS)
 - Decentralized R&D
 
Ceva
 
 - Sales, growth and R&D investment
 - Biomune, Phylaxia and French sites
 - 2016 acquisitions
 - Hatcher automation and in-ovo vaccination
 - India acquisition
 - Brazil--important strategic market
 - Merial swine vaccines acquisition
 
Elanco Animal Health
 
 - Strong technological base
 - Fermentation and chemical synthesis
 - Strong base in antibiotics and anticoccidials
 - Expiration of patents caused restructuring
 - US marketing
 - Lilly Japan
 - Focused marketing strategies
 - Well-established relationship with customers
 - Multi-disciplinary business with diverse product portfolio
 - In the midst of strategic decisions
 - Stepping up efforts to curtail time to market
 - Could divest animal health
 - Changed product mix
 - Strategic collaborations
 - Broadening portfolio of companion animal medicines
 - Hard look at bottom line
 - CEO Dave Ricks
 
Merck Animal Health
 
 - Sales and growth
 - Higher sales of Bravecto
 - Vallée acquisition
 - Extensive know-how in animal health
 - Sphereon technology
 - Expanding worldwide poultry business
 - Poultry biological research laboratories
 - Segmented poultry-product line
 - Mitigated generic competition
 - R&D productivity improving
 - Patents, economies of scale, and powerful intellectual base
 - Keytruda key to future
 
Phibro Animal Health
 
 - Sales and growth
 - Extensive portfolio of antibiotics and antibacterials
 - Sales force, sales offices and distribution network
 - Animal health R&D facilities
 - Biotay acquisition
 
Virbac
 
 - Sales and growth
 - Eli Lilly dog parasiticides acquisition
 - Product portfolio
 - Formulation know-how
 - Waltham nutrition products
 - Reorganized European distribution
 - Decentralized approach for food-producing animals
 - Benefitting from new companion animal products
 - Focusing on niche markets
 - Seeking expansion in the U.S.
 
Zoetis
 
 - Majority of revenue from production animals
 - Largest market share in the industry
 - Poultry and swine revenue declining
 - Scale allows to use own sales force in emerging markets
 - Management continues cost-cutting efforts
 - Reassessing manufacturing infrastructure
 - CEO Juan Ramon Alaix
 - Market-leading position in emerging markets
 - Leading share in Asia-Pacific, Canada and Latin America
 - Fragmented customer base
 - Leading position in fastest-growing markets

Contains 83 pages and 6 tables



To order sections of this report, contact Client Services


     
   
Local PDF: $2450.00
Other Formats: Global PDF, DataPack
   
   
 
VPGMarketResearch.com © Copyright 2015. all rights reserved. Web Design by Spida Design  
  Close  X